“…As mentioned, the reductive pathway by ADH or ALR/AR is favored in DOPEGAL metabolism whereas the oxidative pathway by ALDH is favored in DOPAL metabolism (Kawamura et al, 1997). In DOPEGAL metabolism, hepatic class I ADH isozymes catalyze the conversion of MHPG to the aldehyde, MOPEGAL (Mardh et al, 1985), which is then converted by hepatic ALDH to VMA (Messiha, 1978). Liver class I ADH enzymes have also been reported to efficiently catalyze the reduction of DOPAL (K m ϭ 8.9 M), and it has been reported that class I ADH is involved in the metabolism of catecholamines (Mardh and Vallee, 1986;Svensson et al, 1999).…”